Wenzhou Capital
VC Fund
Xuhui, China
Wenzhou Capital is a mixed-ownership professional investment organization specializing in biopharmaceutical investing.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 38%
Last updated:
For AI agents: llms.txt
Industries Wenzhou Capital invests in
Stages Wenzhou Capital invests in
Countries Wenzhou Capital invests in
Investment Focus
Industry
- Health Care 5 (63%)
- Medical 4 (50%)
- Pharmaceutical 4 (50%)
- Biotechnology 3 (38%)
- Therapeutics 2 (25%)
Stage
- Series B 5 (63%)
- Seed 1 (13%)
- Series A 1 (13%)
- Series C 1 (13%)
Country
- China 6 (75%)
- United States 2 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Puguang Bio
|
Puguang Bio is a developer of in vitro medical diagnostic systems. | Series B / Nov 27, 2025 | |
Subtle Medical
|
Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow.The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant tofacilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers.Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose. | $10M / Series B / May 13, 2024 | |
AnDiConBio
|
developer of respiratory anti-infection drugs, offering high-potential, low-risk products like new anti-influenza and oral anti-new coronavirus. | $27.6M / Series A / Apr 29, 2024 | |
Minova Pharma
|
Minova Pharma focuses on the development of novel medications in the spiritual and medicinal beauty domains. | Series B / Jan 05, 2024 | |
Jinfang Pharmaceutical
|
Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies. | $77.1M / Series C / Dec 31, 2021 | |
Vision Pharmaceutical
|
Vision Pharmaceutical l is a high-tech enterprise dedicated to the research and development of anti-drug resistance drugs. | $15.7M / Seed / Dec 28, 2021 | |
TYK Medicines
|
It is an international innovative biotechnology high-tech company focuses on the research and development of new tumor drugs. | $62.2M / Series B / May 23, 2021 | |
Phanes Therapeutics
|
Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases. Their extensive experience and deep scientific knowledge strongly position us to discover and advance robust therapeutic molecules. Through scientific innovation, we deliver better treatment options for patients. Theirmission is to relentlessly seek scientific and technological solutions to improve the lives of patients globally. | $40M / Series B / May 07, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Wenzhou Capital invest in?
Wenzhou Capital invests primarily in Health Care, Medical and Pharmaceutical startups, most often at Series B and Seed stage. Most of the 8 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Wenzhou Capital last invest?
The most recent investment recorded for Wenzhou Capital closed in Nov 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
